Home/Filings/4/0001127602-25-005280
4//SEC Filing

OZOLINS MARTY V. 4

Accession 0001127602-25-005280

CIK 0000091440other

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 5:25 PM ET

Size

41.3 KB

Accession

0001127602-25-005280

Insider Transaction Report

Form 4
Period: 2025-02-13
OZOLINS MARTY V.
Vice President & Controller
Transactions
  • Exercise/Conversion

    Common Stock

    2025-02-13+221,343.891 total
  • Tax Payment

    Common Stock

    2025-02-13$339.73/sh22$7,4741,321.891 total
  • Award

    Performance Units

    2025-02-13+45618 total
    Common Stock (45 underlying)
  • Exercise/Conversion

    Performance Units

    2025-02-1322596 total
    Common Stock (22 underlying)
  • Exercise/Conversion

    Performance Units

    2025-02-135960 total
    Common Stock (596 underlying)
  • Exercise/Conversion

    Deferred Stock Units

    2025-02-13+5962,783.407 total
    Common Stock (596 underlying)
  • Award

    Stock Option (Right to Buy)

    2025-02-13+1,0681,068 total
    Exercise: $339.73From: 2026-02-13Exp: 2035-02-13Common Stock (1,068 underlying)
  • Award

    Restricted Stock Units

    2025-02-13+250250 total
    From: 2028-02-13Exp: 2028-02-13Common Stock (250 underlying)
  • Award

    Performance Units

    2025-02-13+499499 total
    Common Stock (499 underlying)
Holdings
  • Stock Option (Right to Buy)

    Exercise: $168.70Exp: 2027-02-09Common Stock (800 underlying)
    800
  • Stock Option (Right to Buy)

    Exercise: $155.92Exp: 2029-02-14Common Stock (1,250 underlying)
    1,250
  • Stock Option (Right to Buy)

    Exercise: $161.18Exp: 2028-02-15Common Stock (1,000 underlying)
    1,000
  • Stock Option (Right to Buy)

    Exercise: $155.34Exp: 2030-02-13Common Stock (1,300 underlying)
    1,300
  • Stock Option (Right to Buy)

    Exercise: $189.89Exp: 2031-02-11Common Stock (1,316 underlying)
    1,316
  • Stock Option (Right to Buy)

    Exercise: $211.67Exp: 2032-02-10Common Stock (1,676 underlying)
    1,676
  • Stock Option (Right to Buy)

    Exercise: $249.26From: 2024-02-09Exp: 2033-02-09Common Stock (1,377 underlying)
    1,377
  • Stock Option (Right to Buy)

    Exercise: $269.00From: 2025-02-15Exp: 2034-02-15Common Stock (1,356 underlying)
    1,356
  • Restricted Stock Units

    From: 2026-02-09Exp: 2026-02-09Common Stock (315 underlying)
    315
  • Restricted Stock Units

    From: 2027-02-15Exp: 2027-02-15Common Stock (292 underlying)
    292
  • Performance Units

    Common Stock (629 underlying)
    629
  • Performance Units

    Common Stock (585 underlying)
    585
Footnotes (12)
  • [F1]Based on Company performance during the 2022-2024 period, 107.8% of the performance units vested (as previously disclosed, the reporting person had the opportunity to earn up to 200% of the number originally reported, subject to plan limits). The reporting person elected to defer the receipt of a portion of the underlying shares.
  • [F10]Option fully vested.
  • [F11]If the Company achieves certain goals over the 2023-2025 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
  • [F12]If the Company achieves certain goals over the 2024-2026 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
  • [F2]Shares were withheld to cover tax withholding upon the vesting of performance units.
  • [F3]1 for 1.
  • [F4]Payment will be made in accordance with the reporting person's deferral election, death, disability or termination of employment.
  • [F5]This information is based on a plan statement dated December 31, 2024, as updated by the transaction being reported.
  • [F6]Original stock option grant vests in three annual installments beginning on the date listed in the "Date Exercisable" column.
  • [F7]This transaction was an option grant. Accordingly, the reporting person did not pay a price to obtain the option.
  • [F8]The restricted stock units vest three years from the grant date on the date listed above, assuming continued employment.
  • [F9]If the Company achieves certain goals over the 2025-2027 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.

Issuer

Snap-on Inc

CIK 0000091440

Entity typeother

Related Parties

1
  • filerCIK 0001612770

Filing Metadata

Form type
4
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 5:25 PM ET
Size
41.3 KB